4//SEC Filing
Hershberger Michael D 4
Accession 0001140361-17-034317
CIK 0001561387other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:50 PM ET
Size
37.6 KB
Accession
0001140361-17-034317
Insider Transaction Report
Form 4
Hershberger Michael D
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2017-08-31$34.81/sh−2,500$87,017→ 94,569 total - Sale
Class A Common Stock
2017-09-01$33.74/sh−400$13,495→ 89,569 total - Exercise/Conversion
Class A Common Stock
2017-09-01$10.45/sh+15,000$156,750→ 104,569 total - Exercise/Conversion
Class A Common Stock
2017-09-01$4.99/sh+7,500$37,425→ 112,156 total - Disposition to Issuer
Class A Common Stock
2017-09-01$33.81/sh−1,113$37,631→ 111,043 total - Sale
Class A Common Stock
2017-09-01$33.81/sh−2,222$75,126→ 108,821 total - Sale
Class A Common Stock
2017-09-01$30.45/sh−100$3,045→ 90,769 total - Disposition to Issuer
Class A Common Stock
2017-09-01$28.96/sh−4,659$134,948→ 99,910 total - Sale
Class A Common Stock
2017-09-01$28.96/sh−3,597$104,187→ 96,313 total - Disposition to Issuer
Class A Common Stock
2017-09-01$32.02/sh−2,207$70,660→ 109,106 total - Exercise/Conversion
Stock Appreciation Rights
2017-09-01−15,000→ 10,000 totalExercise: $10.45Exp: 2021-05-21→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Appreciation Rights
2017-09-01−15,000→ 15,000 totalExercise: $4.95Exp: 2022-07-01→ Common Stock (15,000 underlying) - Sale
Class A Common Stock
2017-09-01$28.36/sh−400$11,345→ 94,169 total - Sale
Class A Common Stock
2017-09-01$29.10/sh−3,300$96,027→ 90,869 total - Sale
Class A Common Stock
2017-09-01$32.09/sh−800$25,670→ 89,969 total - Exercise/Conversion
Class A Common Stock
2017-09-01$4.95/sh+15,000$74,250→ 111,313 total - Sale
Class A Common Stock
2017-09-01$32.02/sh−4,450$142,473→ 104,656 total - Exercise/Conversion
Stock Appreciation Rights
2017-09-01−7,500→ 22,500 totalExercise: $4.99Exp: 2022-09-16→ Common Stock (7,500 underlying)
Holdings
- 40,972
Stock Appreciation RIghts
Exercise: $5.20Exp: 2023-09-16→ Common Stock (40,972 underlying)
Footnotes (12)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.75 to $34.90, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.00 to $32.15, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F11]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.80 to $33.90, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F12]Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
- [F2]Sale made pursuant to 10b5-1 plan executed on November 18, 2016.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.85 to $28.70, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.00 to $29.0990, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.90 to $32.85, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.65 to $33.80, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F7]These stock-settled stock appreciation rights were granted under the Long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
- [F8]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.90 to $29.00, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Health Insurance Innovations, Inc.
CIK 0001561387
Entity typeother
Related Parties
1- filerCIK 0001569128
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:50 PM ET
- Size
- 37.6 KB